{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:02:03Z","timestamp":1780336923620,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologie"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00117-026-01623-5","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:25:59Z","timestamp":1779863159000},"page":"481-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Erkennung und Unterscheidung von atypischen hepatozellul\u00e4ren Karzinomen","Detection and differentiation of atypical hepatocellular carcinomas"],"prefix":"10.1007","volume":"66","author":[{"given":"Chiraz","family":"Ben-Salah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Longerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Klau\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"1623_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray\u00a0F et\u00a0al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 74:229\u2013263","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1623_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal\u00a0ID et\u00a0al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182\u2013188","journal-title":"Histopathology"},{"key":"1623_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2214\/AJR.21.26982","volume":"219","author":"LM Loy","year":"2022","unstructured":"Loy\u00a0LM et\u00a0al (2022) Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review. American Journal of Roentgenology 219:212\u2013223","journal-title":"American Journal of Roentgenology"},{"key":"1623_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100380","volume":"3","author":"R Cannella","year":"2021","unstructured":"Cannella\u00a0R et\u00a0al (2021) Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS. JHEP Rep 3:100380","journal-title":"JHEP Rep"},{"key":"1623_CR5","unstructured":"Langer, T. S3-Leitlinie Diagnostik und Therapie des Hepatozellul\u00e4ren Karzinoms und bili\u00e4rer Karzinome. (2025)."},{"key":"1623_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11377-008-0166-1","volume":"3","author":"S Kubicka","year":"2008","unstructured":"Kubicka\u00a0S, Manns\u00a0MP (2008) Hepatozellul\u00e4res Karzinom. Gastroenterologe 3:147\u2013157","journal-title":"Gastroenterologe"},{"key":"1623_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100240","volume":"12","author":"W Gu","year":"2021","unstructured":"Gu\u00a0W et\u00a0al (2021) Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). Lancet Reg Health Eur 12:100240","journal-title":"Lancet Reg Health Eur"},{"key":"1623_CR8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s12325-024-03085-4","volume":"42","author":"R Luthra","year":"2025","unstructured":"Luthra\u00a0R, Sheth\u00a0A (2025) Understanding MASH: An Examination of Progression and Clinical Outcomes by Disease Severity in the TARGET-NASH Database. Adv Ther 42:1165\u20131195","journal-title":"Adv Ther"},{"key":"1623_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.14740\/jocmr4902","volume":"15","author":"E Calderon-Martinez","year":"2023","unstructured":"Calderon-Martinez\u00a0E et\u00a0al (2023) Prognostic Scores and Survival Rates by Etiology of Hepatocellular Carcinoma: A Review. J\u00a0Clin Med Res 15:200\u2013207","journal-title":"J Clin Med Res"},{"key":"1623_CR10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230457","volume":"308","author":"Y Bao","year":"2023","unstructured":"Bao\u00a0Y et\u00a0al (2023) Identifying Proliferative Hepatocellular Carcinoma at Pretreatment CT: Implications for Therapeutic Outcomes after Transarterial Chemoembolization. Radiology 308:e230457","journal-title":"Radiology"},{"key":"1623_CR11","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1007\/s00330-025-12075-1","volume":"36","author":"X Jia","year":"2026","unstructured":"Jia\u00a0X et\u00a0al (2026) Imaging for molecular and pathological subtyping of hepatocellular carcinoma\u2014a critical appraisal and future directions. Eur Radiol 36:2744\u20132763","journal-title":"Eur Radiol"},{"key":"1623_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jmri.29400","volume":"61","author":"M Lu","year":"2025","unstructured":"Lu\u00a0M et\u00a0al (2025) Diagnostic Model for Proliferative HCC Using LI-RADS: Assessing Therapeutic Outcomes in Hepatectomy and TKI-ICI Combination. J\u00a0Magn Reson Imaging 61:134\u2013147","journal-title":"J Magn Reson Imaging"},{"key":"1623_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jhep.2025.10.020","volume":"84","author":"M Reig","year":"2026","unstructured":"Reig\u00a0M et\u00a0al (2026) BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update. Journal of Hepatology 84:631\u2013654","journal-title":"Journal of Hepatology"},{"key":"1623_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10050903","volume":"10","author":"Z Sparchez","year":"2021","unstructured":"Sparchez\u00a0Z et\u00a0al (2021) Ultrasound or Sectional Imaging Techniques as Screening Tools for Hepatocellular Carcinoma: Fall Forward or Move Forward? J\u00a0Clin Med 10:903","journal-title":"J Clin Med"},{"key":"1623_CR15","doi-asserted-by":"publisher","first-page":"6902","DOI":"10.1007\/s00330-023-09669-y","volume":"33","author":"TA Auer","year":"2023","unstructured":"Auer\u00a0TA et\u00a0al (2023) Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5th edition of the World Health Organization classification. Eur Radiol 33:6902\u20136915","journal-title":"Eur Radiol"},{"key":"1623_CR16","doi-asserted-by":"publisher","DOI":"10.1148\/rg.239001","volume":"43","author":"KJ Fowler","year":"2023","unstructured":"Fowler\u00a0KJ et\u00a0al (2023) Universal Liver Imaging Lexicon: Imaging Atlas for Research and Clinical Practice. Radiographics 43:e239001","journal-title":"Radiographics"},{"key":"1623_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.17998\/jlc.2024.04.05","volume":"24","author":"DH Kim","year":"2024","unstructured":"Kim\u00a0DH, Choi\u00a0SH (2024) Inter-reader agreement for CT\/MRI LI-RADS category M imaging features: a systematic review and meta-analysis. JLC 24:192\u2013205","journal-title":"JLC"},{"key":"1623_CR18","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1148\/rg.2021210009","volume":"41","author":"KJ Fowler","year":"2021","unstructured":"Fowler\u00a0KJ et\u00a0al (2021) Pathologic, Molecular, and Prognostic Radiologic Features of Hepatocellular Carcinoma. RadioGraphics 41:1611\u20131631","journal-title":"RadioGraphics"},{"key":"1623_CR19","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221291","volume":"307","author":"Z Feng","year":"2023","unstructured":"Feng\u00a0Z et\u00a0al (2023) CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma. Radiology 307:e221291","journal-title":"Radiology"},{"key":"1623_CR20","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1097\/PAS.0000000000001533","volume":"44","author":"J Qin","year":"2020","unstructured":"Qin\u00a0J et\u00a0al (2020) Steatohepatitic variant of hepatocellular carcinoma is associated with both alcoholic- and non-alcoholic steatohepatitis: A study of two cohorts with molecular insights. Am J Surg Pathol 44:1406\u20131412","journal-title":"Am J Surg Pathol"},{"key":"1623_CR21","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/hep.30858","volume":"71","author":"JD Yang","year":"2020","unstructured":"Yang\u00a0JD et\u00a0al (2020) Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease. Hepatology 71:907\u2013916","journal-title":"Hepatology"},{"key":"1623_CR22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/ajcp\/aqae136","volume":"163","author":"T Zhang","year":"2025","unstructured":"Zhang\u00a0T, Niu\u00a0N, Taddei\u00a0T, Jain\u00a0D, Zhang\u00a0X (2025) Clinicopathologic features and prognosis of steatohepatitic hepatocellular carcinoma based on varying cutoffs of tumoral steatohepatitic changes. American Journal of Clinical Pathology 163:411\u2013418","journal-title":"American Journal of Clinical Pathology"},{"key":"1623_CR23","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1007\/s00330-024-11151-2","volume":"35","author":"L Zhang","year":"2025","unstructured":"Zhang\u00a0L et\u00a0al (2025) Fat fraction quantification by MRI predicts diagnosis and prognosis of HBV-related steatohepatitic hepatocellular carcinoma. Eur Radiol 35:3144\u20133157","journal-title":"Eur Radiol"},{"key":"1623_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.14740\/gr1110","volume":"11","author":"AM Olofson","year":"2018","unstructured":"Olofson\u00a0AM, Gonzalo\u00a0DH, Chang\u00a0M, Liu\u00a0X (2018) Steatohepatitic Variant of Hepatocellular Carcinoma: A Focused Review. Gastroenterol Res 11:391\u2013396","journal-title":"Gastroenterol Res"},{"key":"1623_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13071337","volume":"13","author":"K Chen","year":"2023","unstructured":"Chen\u00a0K et\u00a0al (2023) Contrast-Enhanced Imaging Features and Clinicopathological Investigation of Steatohepatitic Hepatocellular Carcinoma. Diagnostics 13:1337","journal-title":"Diagnostics"},{"key":"1623_CR26","doi-asserted-by":"publisher","first-page":"W411","DOI":"10.2214\/AJR.14.14000","volume":"205","author":"JE Shriki","year":"2015","unstructured":"Shriki\u00a0JE et\u00a0al (2015) CT of Atypical and Uncommon Presentations of Hepatocellular Carcinoma. AJR Am J Roentgenol 205:W411\u2013W423","journal-title":"AJR Am J Roentgenol"},{"key":"1623_CR27","doi-asserted-by":"publisher","first-page":"160.e15","DOI":"10.1016\/j.crad.2020.09.011","volume":"76","author":"S Inui","year":"2021","unstructured":"Inui\u00a0S et\u00a0al (2021) Steatohepatitic hepatocellular carcinoma: imaging findings with clinicopathological correlation. Clinical Radiology 76:160.e15\u2013160.e25","journal-title":"Clinical Radiology"},{"key":"1623_CR28","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s00261-022-03499-0","volume":"47","author":"EJ Park","year":"2022","unstructured":"Park\u00a0EJ, Son\u00a0JH, Choi\u00a0SH (2022) Imaging features of hepatocellular carcinoma in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: a\u00a0systematic review and meta-analysis. Abdom Radiol (NY) 47:2089\u20132098","journal-title":"Abdom Radiol (NY)"},{"key":"1623_CR29","doi-asserted-by":"publisher","first-page":"W7","DOI":"10.2214\/AJR.07.3947","volume":"193","author":"YE Chung","year":"2009","unstructured":"Chung\u00a0YE et\u00a0al (2009) Hepatocellular Carcinoma Variants: Radiologic-Pathologic Correlation. American Journal of Roentgenology 193:W7\u2013W13","journal-title":"American Journal of Roentgenology"},{"key":"1623_CR30","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1007\/s00261-024-04263-2","volume":"49","author":"M Song","year":"2024","unstructured":"Song\u00a0M et\u00a0al (2024) Clear cell hepatocellular carcinoma: Gd-EOB-DTPA-enhanced MR imaging features and prognosis. Abdom Radiol 49:2606\u20132621","journal-title":"Abdom Radiol"},{"key":"1623_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1053\/j.ro.2024.11.001","volume":"60","author":"SP Klimkowski","year":"2025","unstructured":"Klimkowski\u00a0SP et\u00a0al (2025) Update on Hepatocellular Carcinoma Imaging Features Associated With Histology, Subtype, and Prognosis Along With Changes to LI-RADS in 2024. Seminars in Roentgenology 60:6\u201318","journal-title":"Seminars in Roentgenology"},{"key":"1623_CR32","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3748\/wjg.v17.i7.946","volume":"17","author":"QY Liu","year":"2011","unstructured":"Liu\u00a0QY et\u00a0al (2011) Primary clear cell carcinoma in the liver: CT and MRI findings. World J Gastroenterol 17:946\u2013952","journal-title":"World J Gastroenterol"},{"key":"1623_CR33","doi-asserted-by":"publisher","first-page":"30919","DOI":"10.21037\/qims-22-523","volume":"13","author":"S Hu","year":"2023","unstructured":"Hu\u00a0S et\u00a0al (2023) Tumor metabolism derived from 18F-FDG PET\/CT in predicting the macrotrabecular-massive subtype of hepatocellular carcinoma. Quantitative Imaging in Medicine and Surgery 13:30919\u201330319","journal-title":"Quantitative Imaging in Medicine and Surgery"},{"key":"1623_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2023.152134","volume":"64","author":"SH Shin","year":"2023","unstructured":"Shin\u00a0SH et\u00a0al (2023) Histological subtypes of hepatocellular carcinoma: Their clinical and prognostic significance. Annals of Diagnostic Pathology 64:152134","journal-title":"Annals of Diagnostic Pathology"},{"key":"1623_CR35","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2147\/JHC.S364703","volume":"9","author":"A Sessa","year":"2022","unstructured":"Sessa\u00a0A et\u00a0al (2022) Macrotrabecular-Massive Hepatocellular Carcinoma: Light and Shadow in Current Knowledge. J\u00a0Hepatocell Carcinoma 9:661\u2013670","journal-title":"J Hepatocell Carcinoma"},{"key":"1623_CR36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","volume":"71","author":"J Calderaro","year":"2019","unstructured":"Calderaro\u00a0J, Ziol\u00a0M, Paradis\u00a0V, Zucman-Rossi\u00a0J (2019) Molecular and histological correlations in liver cancer. Journal of Hepatology 71:616\u2013630","journal-title":"Journal of Hepatology"},{"key":"1623_CR37","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1007\/s00330-022-08643-4","volume":"32","author":"JK Yoon","year":"2022","unstructured":"Yoon\u00a0JK, Choi\u00a0JY, Rhee\u00a0H, Park\u00a0YN (2022) MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification. Eur Radiol 32:5119\u20135133","journal-title":"Eur Radiol"},{"key":"1623_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.17998\/jlc.20.1.17","volume":"20","author":"H Kim","year":"2020","unstructured":"Kim\u00a0H, Jang\u00a0M, Park\u00a0YN (2020) Histopathological Variants of Hepatocellular Carcinomas: an Update According to the 5th Edition of the WHO Classification of Digestive System Tumors. JLC 20:17\u201324","journal-title":"JLC"},{"key":"1623_CR39","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2147\/JHC.S328198","volume":"8","author":"A Murtha-Lemekhova","year":"2021","unstructured":"Murtha-Lemekhova\u00a0A et\u00a0al (2021) Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features. J\u00a0Hepatocell Carcinoma 8:1269\u20131279","journal-title":"J Hepatocell Carcinoma"},{"key":"1623_CR40","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00330-017-5196-y","volume":"28","author":"SY Choi","year":"2018","unstructured":"Choi\u00a0SY et\u00a0al (2018) Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging. Eur Radiol 28:2549\u20132560","journal-title":"Eur Radiol"},{"key":"1623_CR41","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3348\/kjr.2018.0636","volume":"20","author":"JH Kim","year":"2019","unstructured":"Kim\u00a0JH, Joo\u00a0I, Lee\u00a0JM (2019) Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging. Korean J Radiol 20:1019\u20131041","journal-title":"Korean J Radiol"},{"key":"1623_CR42","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1111\/liv.14975","volume":"41","author":"HJ Kang","year":"2021","unstructured":"Kang\u00a0HJ et\u00a0al (2021) Clinicopathological and molecular characterization of chromophobe hepatocellular carcinoma. Liver International 41:2499\u20132510","journal-title":"Liver International"},{"key":"1623_CR43","doi-asserted-by":"crossref","unstructured":"Ben-Slama\u00a0S et\u00a0al CHROMOPHOBE HEPATOCELLULAR CARCINOMA: DIAGNOSTIC CHALLENGES. Arq Bras Cir Dig 37:e1863","DOI":"10.1590\/0102-6720202400069e1863"},{"key":"1623_CR44","volume-title":"StatPearls","author":"M Smith","year":"2025","unstructured":"Smith\u00a0M, Tomboc\u00a0PJ, Markovich\u00a0B (2025) Fibrolamellar Hepatocellular Carcinoma. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"1623_CR45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.17998\/jlc.2022.06.10","volume":"22","author":"SK Na","year":"2022","unstructured":"Na\u00a0SK (2022) Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a\u00a0case report. JLC 22:178\u2013182","journal-title":"JLC"},{"key":"1623_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4240\/wjgs.v9.i2.61","volume":"9","author":"MA Wahab","year":"2017","unstructured":"Wahab\u00a0MA, Hanafy\u00a0EE, Nakeeb\u00a0AE, Ali\u00a0MA (2017) Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22\u00a0patients over a\u00a015-year period). World Journal of Gastrointestinal Surgery 9:61\u201367","journal-title":"World Journal of Gastrointestinal Surgery"},{"key":"1623_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21037\/cco.2018.08.08","volume":"7","author":"VA Chaudhari","year":"2018","unstructured":"Chaudhari\u00a0VA, Khobragade\u00a0K, Bhandare\u00a0M, Shrikhande\u00a0SV (2018) Management of fibrolamellar hepatocellular carcinoma. Chinese Clinical Oncology 7:51\u201351","journal-title":"Chinese Clinical Oncology"},{"key":"1623_CR48","unstructured":"Focal Liver Lesions | SpringerLink. https:\/\/link.springer.com\/chapter\/10.1007\/978-3-319-75019-4_17?utm_source=chatgpt.com."},{"key":"1623_CR49","doi-asserted-by":"crossref","unstructured":"Vij, M. et\u00a0al. Clinicopathological Characteristics of Neutrophil-Rich Hepatocellular Carcinoma: An Uncommon Subtype of Primary Liver Cancer. Int J Surg Pathol 33, 828\u2013841 (2025).","DOI":"10.1177\/10668969241291882"}],"container-title":["Die Radiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-026-01623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-026-01623-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-026-01623-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:01:48Z","timestamp":1780333308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-026-01623-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1623"],"URL":"https:\/\/doi.org\/10.1007\/s00117-026-01623-5","relation":{},"ISSN":["2731-7048","2731-7056"],"issn-type":[{"value":"2731-7048","type":"print"},{"value":"2731-7056","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"C.\u00a0Ben-Salah:\n                      A.\u00a0Finanzielle Interessen:\n                      C.\u00a0Ben-Salah\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellte Fach\u00e4rztin f\u00fcr Radiologie im Universit\u00e4tsklinikum Heidelberg; Nebent\u00e4tigkeit: Fach\u00e4rztin f\u00fcr Radiologie in der MVZ Praxis Heidelberg | Mitgliedschaften: DRG, ESR. P\n                      .\u00a0Mayer:\n                      A.\u00a0Finanzielle Interessen:\n                      P.\u00a0Mayer\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt, Diagnostische und Interventionelle Radiologie, Universit\u00e4tsklinikum Heidelberg | Mitgliedschaften: DRG, VSRN.\n                      T.\u00a0Longerich:\n                      A.\u00a0Finanzielle Interessen:\n                      T.\u00a0Longerich\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Ltd. OA, Pathologisches Institut, Uniklinikum Heidelberg | Mitgliedschaften: GASL, DGP, ESP, Laennec Liver Pathology Society.\n                      M.\u00a0Klau\u00df:\n                      A.\u00a0Finanzielle Interessen:\n                      M.\u00a0Klau\u00df\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Stellv. \u00e4rztliche Direktorin u.\u00a0Ltd. Ober\u00e4rztin, Universit\u00e4tsklinikum Heidelberg, Klinik f\u00fcr Diagnostische und Interventionelle Radiologie | Mitgliedschaften: DRG (AG Abdominelle Radiologie, AG Uroradiologie, AG Herz & Gef\u00e4\u00df, AG MSK), DeGIR, CIRSE, ESR.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}